Feb. 1, 2006 — Nanotherapeutics Inc., a privately held corporation focused on the development and application of proprietary drug delivery systems, announced today the appointment of Mento A. “Chuck” Soponis as chairman and chief executive. Soponis was president and CEO of Oragenics Inc., a company he brought public and listed on the AMEX in 2003.
Based in Alachua, Fla., Nanotherapeutics is a provider of specialized drug delivery systems that use the company’s discoveries in nanotechnology to develop novel drug therapies or improved formulations for existing therapies.